NasdaqCM:CATS

Stock Analysis Report

Executive Summary

Catasys, Inc. provides big data predictive analytics, artificial intelligence and telehealth, and human intervention services to health plans and other third party payors.

Snowflake

Fundamentals

Limited growth with weak fundamentals.

Share Price & News

How has Catasys's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

12.4%

NasdaqCM:CATS

0.6%

US Healthcare

1.1%

US Market


1 Year Return

36.7%

NasdaqCM:CATS

-7.7%

US Healthcare

2.1%

US Market

CATS outperformed the Healthcare industry which returned -8.2% over the past year.

CATS outperformed the Market in United States of America which returned 2% over the past year.


Share holder returns

CATSIndustryMarket
7 Day12.4%0.6%1.1%
30 Day8.3%-0.9%3.7%
90 Day-8.7%0.02%2.3%
1 Year36.7%36.7%-6.3%-7.7%4.4%2.1%
3 Year136.1%136.1%31.5%26.2%47.0%37.4%
5 Year42.4%42.4%65.6%55.8%61.6%43.8%

Price Volatility Vs. Market

How volatile is Catasys's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Catasys undervalued based on future cash flows and its price relative to the stock market?


In this section, we usually try to help investors determine whether Catasys is trading at an attractive price based on the cash flow it is expected to produce in the future. But as Catasys has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.

This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis.


Next Steps

Future Growth

How is Catasys expected to perform in the next 1 to 3 years based on estimates from 4 analysts?

45.3%

Forecasted annual earnings growth


Earnings and Revenue Growth Estimates


Future Annual Growth Analysis

Catasys's revenue is expected to grow significantly at over 20% yearly.

Catasys is not considered high growth as it is expected to be loss making for the next 1-3 years.

Catasys's revenue growth is expected to exceed the United States of America market average.

Unable to compare Catasys's earnings growth to the United States of America market average as it is expected to be loss making during the next 1-3 years.

Unable to compare Catasys's earnings growth to the low risk savings rate as it is expected to be loss making during the next 1-3 years.


Earnings per Share Growth Estimates


Future Return on Equity

Unable to establish if Catasys will efficiently use shareholders’ funds in the future without estimates of Return on Equity.


Next Steps

Past Performance

How has Catasys performed over the past 5 years?

12.0%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Catasys does not make a profit even though their year on year earnings growth rate was positive over the past 5 years.

Unable to compare Catasys's 1-year earnings growth to the 5-year average as it is not currently profitable.

Unable to compare Catasys's 1-year growth to the US Healthcare industry average as it is not currently profitable.


Return on Equity

It is difficult to establish if Catasys has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) due to its liabilities exceeding its assets.


Return on Assets

It is difficult to establish if Catasys has efficiently used its assets last year compared to the US Healthcare industry average (Return on Assets) as it is loss-making.


Return on Capital Employed

It is difficult to establish if Catasys improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.


Next Steps

Financial Health

How is Catasys's financial position?


Financial Position Analysis

Catasys's short term (1 year) commitments are greater than its holdings of cash and other short term assets.

Catasys's long term commitments exceed its cash and other short term assets.


Debt to Equity History and Analysis

Catasys has negative shareholder equity (liabilities exceed assets), this is a more serious situation compared with a high debt level.

Irrelevant to check if Catasys's debt level has increased considering it has negative shareholder equity.


Balance Sheet

Low level of unsold assets.

Catasys has negative shareholder equity (liabilities exceed assets) therefore debt is not covered by short term assets.


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Catasys has less than a year of cash runway based on current free cash flow.

Catasys has less than a year of cash runway if free cash flow continues to grow at historical rates of 21.7% each year.


Next Steps

Dividend

What is Catasys's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate Catasys's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate Catasys's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as Catasys has not reported any payouts.

Unable to verify if Catasys's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as Catasys has not reported any payouts.


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of Catasys's salary, the management and board of directors tenure and is there insider trading?

2.3yrs

Average management tenure


CEO

Terren Peizer (59yo)

16.6yrs

Tenure

US$2,411,806

Compensation

Mr. Terren S. Peizer has been Chairman of BioVie Inc and also serves as its Chief Executive Officer and Director since July 3, 2018. He is Founder of Neurmedix, Inc. and serves as its Chairman and Chief Ex ...


CEO Compensation Analysis

Terren's remuneration is higher than average for companies of similar size in United States of America.

Terren's compensation has increased whilst company is loss making.


Management Age and Tenure

2.3yrs

Average Tenure

47.5yo

Average Age

The tenure for the Catasys management team is about average.


Board Age and Tenure

0.9yrs

Average Tenure

58.5yo

Average Age

The average tenure for the Catasys board of directors is less than 3 years, this suggests a new board.


Insider Trading

No 3 month open market individual insider trading information.


Recent Insider Transactions

SellUS$3,829,45316 Jul 19
Coast Asset Management, LLC
EntityCompany
Shares195,197
Max PriceUS$19.86
SellUS$4,183,15002 Jul 19
Coast Asset Management, LLC
EntityCompany
Shares224,286
Max PriceUS$19.95
SellUS$2,231,09422 May 19
Coast Asset Management, LLC
EntityCompany
Shares115,000
Max PriceUS$19.91
SellUS$778,91416 May 19
Coast Asset Management, LLC
EntityCompany
Shares42,229
Max PriceUS$18.45
SellUS$627,23015 May 19
Coast Asset Management, LLC
EntityCompany
Shares34,500
Max PriceUS$18.27
SellUS$288,59410 May 19
Coast Asset Management, LLC
EntityCompany
Shares16,692
Max PriceUS$18.24
SellUS$2,713,80708 May 19
Coast Asset Management, LLC
EntityCompany
Shares164,031
Max PriceUS$17.16
SellUS$801,89529 Apr 19
Coast Asset Management, LLC
EntityCompany
Shares50,815
Max PriceUS$15.98
SellUS$2,034,69425 Apr 19
Coast Asset Management, LLC
EntityCompany
Shares135,773
Max PriceUS$15.28
SellUS$1,37411 Apr 19
Coast Asset Management, LLC
EntityCompany
Shares99
Max PriceUS$13.88
SellUS$447,91003 Apr 19
Coast Asset Management, LLC
EntityCompany
Shares31,814
Max PriceUS$14.09
SellUS$596,28126 Mar 19
Coast Asset Management, LLC
EntityCompany
Shares43,037
Max PriceUS$13.92
SellUS$1,39522 Mar 19
Coast Asset Management, LLC
EntityCompany
Shares100
Max PriceUS$13.95
SellUS$105,22522 Mar 19
Coast Asset Management, LLC
EntityCompany
Shares7,543
Max PriceUS$13.95
SellUS$679,99721 Mar 19
Coast Asset Management, LLC
EntityCompany
Shares47,951
Max PriceUS$14.23
SellUS$390,96520 Mar 19
Coast Asset Management, LLC
EntityCompany
Shares27,645
Max PriceUS$14.19

Ownership Breakdown


Management Team

  • Rick Anderson (50yo)

    President & COO

    • Tenure: 11.2yrs
    • Compensation: US$1.30m
  • Terren Peizer (59yo)

    Founder

    • Tenure: 16.6yrs
    • Compensation: US$2.41m
  • Michael Green

    Director of Business Development

    • Tenure: 0yrs
  • Greg McLane

    Chief Marketing & Strategy Officer

    • Tenure: 4yrs
  • Susan Etzel (45yo)

    Senior Vice President of Finance

    • Tenure: 2.3yrs
    • Compensation: US$170.00k
  • Omar Manejwala

    Chief Medical Officer & Senior VP

    • Tenure: 7.8yrs
  • Christopher Shirley (43yo)

    Chief Financial Officer

    • Tenure: 2.3yrs
    • Compensation: US$316.01k
  • Jeremiah Stone

    Chief Technology Officer

    • Tenure: 1.2yrs
  • Carol Murdock

    Chief Commercial Officer

    • Tenure: 0.5yrs
  • J. Prewitt

    Senior Vice President of Sales

    • Tenure: 0.3yrs

Board Members

  • Ed Zecchini (58yo)

    Director

    • Tenure: 0.8yrs
    • Compensation: US$43.96k
  • Richard Berman (73yo)

    Independent Director

    • Tenure: 5.6yrs
    • Compensation: US$131.59k
  • Rob Rebak

    Director

    • Tenure: 0.2yrs
  • Terren Peizer (59yo)

    Founder

    • Tenure: 16.6yrs
    • Compensation: US$2.41m
  • Diane Seloff (55yo)

    Director

    • Tenure: 0.9yrs
    • Compensation: US$39.46k
  • Sharon Gabrielson (57yo)

    Director

    • Tenure: 0.9yrs
    • Compensation: US$43.96k
  • Michael Sherman (60yo)

    Director

    • Tenure: 2.2yrs
    • Compensation: US$123.67k

Company Information

Catasys, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Catasys, Inc.
  • Ticker: CATS
  • Exchange: NasdaqCM
  • Founded: 2003
  • Industry: Health Care Services
  • Sector: Healthcare
  • Market Cap: US$281.299m
  • Shares outstanding: 16.55m
  • Website: https://catasys.com

Number of Employees


Location

  • Catasys, Inc.
  • 2120 Colorado Boulevard
  • Suite 230
  • Santa Monica
  • California
  • 90404
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
CATSNasdaqCM (Nasdaq Capital Market)YesCommon StockUSUSDSep 2003

Biography

Catasys, Inc. provides big data predictive analytics, artificial intelligence and telehealth, and human intervention services to health plans and other third party payors. The company offers OnTrak solutio ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/09/16 23:42
End of Day Share Price2019/09/16 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.